GO
Loading...

Biogen Idec Inc

More

  • Final Glance: Biotechnology companies Friday, 29 Aug 2014 | 6:07 PM ET

    Amgen Inc. rose$. 69 or. 5 percent, to $139.38. Biogen Idec rose $1.80 or. 5 percent, to $343.04. Celgene Corp. rose$. 32 or. 3 percent, to $95.02.

  • Midday Glance: Biotechnology companies Friday, 29 Aug 2014 | 1:19 PM ET

    Amgen Inc. rose$. 83 or. 6 percent, to $139.52. Biogen Idec fell$. 11 or percent, to $341.13. Celgene Corp. rose$. 18 or. 2 percent, to $94.88.

  • Early Glance: Biotechnology companies Friday, 29 Aug 2014 | 10:31 AM ET

    Amgen Inc. rose$. 14 or. 1 percent, to $138.83. Biogen Idec fell$. 74 or. 2 percent, to $340.50. Celgene Corp. fell$. 23 or. 2 percent, to $94.47.

  • Final Glance: Biotechnology companies Thursday, 28 Aug 2014 | 6:02 PM ET

    Amgen Inc. rose$. 86 or. 6 percent, to $138.69. Biogen Idec fell $2.12 or. 6 percent, to $341.24. Celgene Corp. fell$. 04 or percent, to $94.70.

  • Midday Glance: Biotechnology companies Thursday, 28 Aug 2014 | 1:19 PM ET

    Amgen Inc. rose $1.07 or. 8 percent, to $138.90. Biogen Idec fell $1.58 or. 5 percent, to $341.78. Celgene Corp. rose$. 01 or percent, to $94.75.

  • Final Glance: Biotechnology companies Wednesday, 27 Aug 2014 | 6:02 PM ET

    Amgen Inc. rose$. 56 or. 4 percent, to $137.83. Biogen Idec rose$. 37 or. 1 percent, to $343.36. Celgene Corp. fell$. 92 or 1.0 percent, to $94.74.

  • Aug 27- Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.

  • Early Glance: Biotechnology companies Wednesday, 27 Aug 2014 | 10:17 AM ET

    Amgen Inc. rose$. 09 or. 1 percent, to $137.36. Biogen Idec fell $3.75 or 1.1 percent, to $339.24. Celgene Corp. fell$. 64 or. 7 percent, to $95.02.

  • Final Glance: Biotechnology companies Tuesday, 26 Aug 2014 | 6:05 PM ET

    Amgen Inc. rose $2.48 or 1.8 percent, to $137.27. Biogen Idec rose$. 29 or. 1 percent, to $342.99. Celgene Corp. rose $2.26 or 2.4 percent, to $95.66.

  • Midday Glance: Biotechnology companies Tuesday, 26 Aug 2014 | 1:31 PM ET

    Amgen Inc. rose $2.37 or 1.8 percent, to $137.16. Biogen Idec fell $1.54 or. 4 percent, to $341.16. Celgene Corp. rose $2.04 or 2.2 percent, to $95.44.

  • Early Glance: Biotechnology companies Tuesday, 26 Aug 2014 | 11:11 AM ET

    Amgen Inc. rose$. 91 or. 7 percent, to $135.70. Biogen Idec fell $1.34 or. 4 percent, to $341.36. Celgene Corp. rose $1.02 or 1.1 percent, to $94.42.

  • Final Glance: Biotechnology companies Monday, 25 Aug 2014 | 6:24 PM ET

    Amgen Inc. rose $1.97 or 1.5 percent, to $134.79. Biogen Idec rose $2.73 or. 8 percent, to $342.70. Celgene Corp. rose $1.78 or 1.9 percent, to $93.40.

  • Bankers and lawyers providing takeover advice said on Monday that Burger King Worldwide Inc's intention to move its tax domicile overseas through a so-called inversion deal- in this case the purchase of Canada's Tim Hortons- shouldn't be seen as a sign of a lot more deals to come.

  • Early Glance: Biotechnology companies Monday, 25 Aug 2014 | 10:37 AM ET

    Amgen Inc. rose $1.75 or 1.3 percent, to $134.57. Biogen Idec rose $4.39 or 1.3 percent, to $344.36. Celgene Corp. rose $1.61 or 1.8 percent, to $93.23.

  • Final Glance: Biotechnology companies Friday, 22 Aug 2014 | 6:02 PM ET

    Amgen Inc. rose$. 29 or. 2 percent, to $132.82. Biogen Idec rose $1.32 or. 4 percent, to $339.97. Celgene Corp. fell$. 04 or percent, to $91.62.

  • Midday Glance: Biotechnology companies Friday, 22 Aug 2014 | 1:21 PM ET

    Amgen Inc. rose$. 73 or. 6 percent, to $133.26. Biogen Idec rose $2.22 or. 7 percent, to $340.87. Celgene Corp. rose$. 09 or. 1 percent, to $91.75.

  • Final Glance: Biotechnology companies Thursday, 21 Aug 2014 | 6:08 PM ET

    Amgen Inc. fell$. 15 or. 1 percent, to $132.53. Biogen Idec fell $3.93 or 1.1 percent, to $338.65. Celgene Corp. fell$. 34 or. 4 percent, to $91.66.

  • Midday Glance: Biotechnology companies Thursday, 21 Aug 2014 | 1:22 PM ET

    Amgen Inc. rose$. 03 or percent, to $132.71. Biogen Idec fell $2.14 or. 6 percent, to $340.45. Celgene Corp. rose$. 02 or percent, to $92.02.

  • Aug 21- Baxter International Inc said a more potent version of its flagship blood disorder drug Advate met the main goal in a late-stage study.

  • Final Glance: Biotechnology companies Wednesday, 20 Aug 2014 | 6:02 PM ET

    Amgen Inc. fell$. 34 or. 3 percent, to $132.68. Biogen Idec fell $3.26 or. 9 percent, to $342.58. Celgene Corp. rose$. 64 or. 7 percent, to $92.00.